barr 400mg 590 Pill: red & white , capsule/oblong, 23mm
The pill with imprint barr 400mg 590 (Red & White, Capsule/Oblong1) has been identified as Didanosine 400 mg and is used for HIV Infection, and Nonoccupational Exposure. It belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is not a controlled substance.
Images for barr 400mg 590
Didanosine
- Imprint
- barr 400mg 590
- Strength
- 400 mg
- Color
- Red & White
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
ferrosoferric oxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Red No. 40,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
hypromellose 2910 (50 mPa.s),
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
microcrystalline cellulose,
polydextrose,
polyethylene glycol 8000,
propylene glycol,
shellac,
silicon dioxide,
sodium hydroxide,
magnesium silicate,
titanium dioxide,
triacetin,
triethyl citrate,
D&C Red No. 33,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00555-0590 (Discontinued) | Barr Laboratories, Inc. |
| 35356-0259 | Lake Erie Medical and Surgical Supply (repackager) |
| 54569-5643 (Discontinued) | A-S Medication Solutions, LLC (repackager) |
See also:
More about didanosine
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.